Antiepileptics Part 2: Absence Seizures, Newer Agents & Status Epilepticus
A child who keeps 'blanking out' in class for a few seconds isn't daydreaming — she may be having dozens of tiny seizures a day. And the drug that stops them is useless against other seizure types, while the common drugs for those can make hers WORSE. Add the newer, cleaner agents and the true emergency — a seizure that won't stop — and you have the rest of the antiepileptic story.
A teacher keeps noticing a nine-year-old girl 'switching off' for a few seconds — she stops mid-sentence, stares blankly, sometimes her eyelids flutter, then she carries on as if nothing happened, unaware she paused. It's labelled as inattention until a doctor recognizes it: these are absence seizures, brief episodes where a specific thalamic rhythm hijacks consciousness. They demand a very specific drug — and, crucially, some of the common seizure drugs from Part 1 would make them worse.
Absence seizures and the calcium channel
Absence seizures have a unique mechanism. Unlike the sodium-driven storms of Part 1, absence seizures are generated by T-type calcium channels in the thalamus creating an abnormal 3-per-second rhythm. That's why they need a targeted drug: ethosuximide blocks exactly these T-type channels and is the first-line treatment — but it does ONLY absence seizures and nothing else. Valproate (from Part 1) also works, because its broad action covers absence too. The trap: the sodium-channel drugs like carbamazepine can actually WORSEN absence seizures, so recognizing the seizure type before choosing a drug is essential.
The newer, cleaner agents
Modern antiepileptics aim for broad coverage with fewer interactions. Lamotrigine blocks sodium channels but is broad-spectrum and generally well-tolerated — its one caution is a slow start, because titrating too fast can trigger a serious rash (Stevens–Johnson); it's also a mood stabilizer and relatively safe in pregnancy. Levetiracetam works by a completely different route (binding a synaptic vesicle protein, SV2A), has very few drug interactions, and has become hugely popular — its main downside is mood and behaviour changes (irritability). Topiramate is broad but can cause word-finding difficulty, weight loss, kidney stones, and glaucoma. Gabapentin and pregabalin act on calcium channels and are used more for neuropathic pain and anxiety than for epilepsy itself.
- Absence seizures come from thalamic T-type Ca²⁺ channels; ethosuximide (or valproate) treats them.
- Sodium-channel drugs (carbamazepine) can WORSEN absence seizures.
- Lamotrigine (broad, slow titration for rash), levetiracetam (SV2A, few interactions) are modern go-tos.
- Gabapentin/pregabalin are used mainly for neuropathic pain, not epilepsy.
Status epilepticus: the true emergency
Most seizures stop by themselves. But a seizure lasting more than about five minutes, or repeated seizures without recovery in between, is status epilepticus — a life-threatening emergency, because prolonged seizing damages the brain and the body. The treatment follows a clear, escalating protocol. First, secure airway, breathing, and circulation. First-line drug: a benzodiazepine (IV lorazepam, or intramuscular/buccal midazolam if there's no IV) to force GABA inhibition and break the seizure fast. Second-line, if it continues: an IV antiepileptic load — levetiracetam, fosphenytoin, or valproate. Third-line, for refractory status: general anaesthesia (a propofol or midazolam infusion) to shut the brain down under intensive-care monitoring.
In status epilepticus, speed matters more than anything — every extra minute of seizing worsens the outcome. A benzodiazepine is chosen first because it works within minutes, powerfully boosting GABA to slam the brakes on the storm. The slower antiepileptic loads come second to keep the seizure from returning. It's the GABA system from the sedatives articles, deployed as an emergency brake.
Choosing an antiepileptic is really about matching spectrum to seizure type AND the individual patient. Broad-spectrum drugs (valproate, lamotrigine, levetiracetam) cover most seizures; narrow ones (ethosuximide for absence, carbamazepine for focal) are precise but can worsen the wrong type. Then the patient tips the balance: for a woman who could become pregnant, avoid valproate and favour lamotrigine or levetiracetam. Right drug, right seizure, right patient.
- Giving carbamazepine/phenytoin for absence seizures. They can make them worse — use ethosuximide/valproate.
- Titrating lamotrigine too fast. It risks a severe rash (Stevens–Johnson) — go slow.
- Treating status epilepticus with a slow drug first. Give a benzodiazepine first for speed.
- Forgetting airway/breathing come before drugs in status epilepticus.
A child has absence seizures. Which drug is first-line — and which could make them worse?
- Absence seizures = thalamic T-type Ca²⁺ rhythm; treat with ethosuximide or valproate.
- Sodium-channel drugs can worsen absence — match the drug to the seizure type.
- Lamotrigine (slow titration) & levetiracetam (few interactions) are broad, modern choices.
- Status epilepticus: airway first, then a benzodiazepine, then IV load, then anaesthesia.
- Katzung BG. Basic & Clinical Pharmacology — Antiseizure Drugs (absence, newer agents & status epilepticus).
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Pharmacotherapy of the epilepsies.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Antiepileptic drugs.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Newer antiepileptics.
- Neurocritical Care Society / ILAE — Status epilepticus treatment protocol.
